Literature DB >> 12832446

Proteinase-3 directly activates MMP-2 and degrades gelatin and Matrigel; differential inhibition by (-)epigallocatechin-3-gallate.

Elga Pezzato1, Massimo Donà, Luigi Sartor, Isabella Dell'Aica, Roberto Benelli, Adriana Albini, Spiridione Garbisa.   

Abstract

Proteinase-3 (PR-3), a serine-proteinase mainly expressed by polymorphonuclear leukocytes (PMNs), can degrade a variety of extracellular matrix proteins and may contribute to a number of inflammation-triggered diseases. Here, we show that in addition to Matrigel(TM) components, PR-3 is also able to degrade denatured collagen and directly activate secreted but not membrane-bound pro-MMP-2, a matrix metallo-proteinase instrumental to cellular invasion. In contrast, following addition of purified PR-3 or PMNs to HT1080 tumor cells, dose-dependent inhibition of in vitro Matrigel(TM) invasion is registered. (-)Epigallocatechin-3-gallate (EGCG), the main flavanol in green tea and known to inhibit inflammation and tumor invasion, exerts dose-dependent inhibition of degradation of gelatin (IC(50)<20 micro M) and casein, which is directly triggered by PR-3. The presence of EGCG does not modify the colocalization of MMP-2 and exogenous PR-3 at the cell surface and does not restrain secreted pro-MMP-2 and pro-MMP-9 activation or degradation of a specific, synthetic peptide by PR-3. These results add new activities to the list of those exerted by PR-3 and indicate a differential inhibition as a result of EGCG.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832446     DOI: 10.1189/jlb.0203086

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Cross-talk between NADPH oxidase-PKCα-p(38)MAPK and NF-κB-MT1MMP in activating proMMP-2 by ET-1 in pulmonary artery smooth muscle cells.

Authors:  Jaganmay Sarkar; Animesh Chowdhury; Tapati Chakraborti; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2016-02-24       Impact factor: 3.396

2.  EphrinA1 is released in three forms from cancer cells by matrix metalloproteases.

Authors:  Amanda Beauchamp; Mark O Lively; Akiva Mintz; Denise Gibo; Jill Wykosky; Waldemar Debinski
Journal:  Mol Cell Biol       Date:  2012-06-11       Impact factor: 4.272

3.  Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.

Authors:  Tarik Touil; Bogoljub Ciric; Elvira Ventura; Kenneth S Shindler; Bruno Gran; Abdolmohamad Rostami
Journal:  J Neurol Sci       Date:  2008-06-10       Impact factor: 3.181

4.  Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine.

Authors:  Raffaele Altara; Marco Manca; Ramzi Sabra; Assaad A Eid; George W Booz; Fouad A Zouein
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

5.  PR3 levels are impaired in plasma and PBMCs from Arabs with cardiovascular diseases.

Authors:  Abdelkrim Khadir; Dhanya Madhu; Sina Kavalakatt; Preethi Cherian; Monira Alarouj; Abdullah Bennakhi; Jehad Abubaker; Ali Tiss; Naser Elkum
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

Review 6.  The Role of Colchicine in Atherosclerosis: From Bench to Bedside.

Authors:  Leticia González; Juan Francisco Bulnes; María Paz Orellana; Paula Muñoz Venturelli; Gonzalo Martínez Rodriguez
Journal:  Pharmaceutics       Date:  2022-07-01       Impact factor: 6.525

Review 7.  Green tea and prostate cancer: from bench to clinic.

Authors:  Mitali Pandey; Sanjay Gupta
Journal:  Front Biosci (Elite Ed)       Date:  2009-06-01

8.  Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not development of pulmonary fibrosis.

Authors:  Anthony N Habgood; Amanda L Tatler; Joanne Porte; Sharon M Wahl; Geoffrey J Laurent; Alison E John; Simon R Johnson; Gisli Jenkins
Journal:  Lab Invest       Date:  2016-03-14       Impact factor: 5.662

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.